Cross-sectional and longitudinal association between homocysteine, vitamin B12 and physical performance in older persons

European Journal of Clinical Nutrition

Volumn 66, Issue 2, 2012, Pages 174-181

  Van Schoor, N M ^a   Swart, K M A ^a   Pluijm, S M F ^b   Visser, M ^a,c   Simsek, S ^d   Smulders, Y ^a   Lips, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d Location Alkmaar   (Netherlands)

Author keywords

homocysteine; older people; physical performance; vitamin B12

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; EXERCISE TEST; FEMALE; HOMOCYSTEINE; HUMANS; LONGITUDINAL STUDIES; MALE; MOVEMENT; NETHERLANDS; PHYSICAL FITNESS; RISK FACTORS; SEX FACTORS; VITAMIN B 12; WALKING;

EID: 84856636496     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2011.151     Document Type: Article

References (39)

1. Agresti A (2002). Categorical Data Analysis, 2nd edn. John Wiley & Sons Inc.: New York.
2. Allen LH (2009). How common is vitamin B-12 deficiency? Am J Clin Nutr 89, 693S-696S.
3. Carmel R (2000). Current concepts in cobalamin deficiency. Annu Rev Med 51, 357-375. (Pubitemid 30216043)
4. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP (2009). Elevated homocysteine is a predictor of all-cause mortality in a prospective cohort of renal transplant recipients. Nephron Clin Pract 114, c5-c11.
5. Dali-Youcef N, Andres E (2009). An update on cobalamin deficiency in adults. QJM 102, 17-28.
6. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le CS et al. (2009). Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338, a3083.
7. Deeg DJH, van Tilburg T, Smit JH, de Leeuw ED (2002). Attrition in the longitudinal aging study Amsterdam: the effect of differential inclusion in side studies. J Clin Epidemiol 55, 319-328. (Pubitemid 34240483)
8. Deeg DJH, Westendorp-de Seriere M (1994). In Autonomy and Well-Being in the Aging Population I: Report from the Longitudinal Aging Study Amsterdam 1992-1993. VU University Press: Amsterdam.
9. Dhonukshe-Rutten RAM, Pluijm SMF, de Groot LCPG, Lips P, Smit JH, van Staveren W (2005). Homocysteine and vitamin B-12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 20, 921-929. (Pubitemid 40712815)
10. Garretsen HFL (1983). Probleemdrinken: Prevalentiebepaling, beÿnvloedende factoren en preventiemogelijkheden: Theoretische overwegingen en onderzoek in Rotterdam. Swets & Zeitlinger: Lisse.
11. Gerdhem P, Ivaska KK, Isaksson A, Pettersson K, Vaananen HK, Obrant KJ et al. (2007). Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 22, 127-134. (Pubitemid 46032605)
12. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG et al. (1994). A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49, M85-M94. (Pubitemid 24100267)
13. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM et al. (2007). Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the sacramento area latino study on aging. Am J Clin Nutr 85, 511-517. (Pubitemid 46220956)
14. Hamer M, Kivimaki M, Yerramasu A, Lahiri A, Deanfield JE, Marmot MG et al. (2009). Walking speed and subclinical atherosclerosis in healthy older adults: the Whitehall Ii study. Heart 96, 380-384.
15. Homocysteine Lowering Trialists' Collaboration (2005). Dose-dependent effects of folic acid on blood concentrations of homo-cysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82, 806-812.
16. Homocysteine Studies Collaboration (2002). Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288, 2015-2022.
17. Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW et al. (1999). Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 69, 482-489. (Pubitemid 29104570)
18. Kado DM, Bucur A, Selhub J, Rowe JW, Seeman T (2002). Homo-cysteine levels and decline in physical function: MacArthur studies of successful aging. Am J Med 113, 537-542. (Pubitemid 35379907)
19. Kuo HK, Liao KC, Leveille SG, Bean JF, Yen CJ, Chen JH et al. (2007). Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults. J Gerontol A Biol Sci Med Sci 62, 434-439. (Pubitemid 47071702)
20. Longstreth Jr WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA et al. (1996). Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27, 1274-1282. (Pubitemid 26286152)
21. Mccullagh P (1980). Regression models for ordinal data. J R Stat Soc Ser B Methodol 42, 109-142.
22. McDermott MM, Ferrucci L, Guralnik JM, Tian L, Green D, Liu K et al. (2007). Elevated levels of inflammation, d-dimer, and homo-cysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol 50, 897-905. (Pubitemid 47277498)
23. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE et al. (2004). Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350, 2042-2049. (Pubitemid 38596555)
24. Ntaios G, Savopoulos C, Grekas D, Hatzitolios A (2009). The controversial role of B-vitamins in cardiovascular risk: an update. Arch Cardiovasc Dis 102, 847-854.
25. Ostir GV, Kuo YF, Berges IM, Markides KS, Ottenbacher KJ (2007). Measures of lower body function and risk of mortality over 7 years of follow-up. Am J Epidemiol 166, 599-605. (Pubitemid 47283641)
26. Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P (2005). Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 63, 403-411. (Pubitemid 41442334)
27. Ravaglia G, Forti P, Maioli F, Montesi F, Rietti E, Pisacane N et al. (2007). Risk factors for dementia: data from the Conselice study of brain aging. Arch Gerontol Geriatr 44(Suppl 1), 311-320.
28. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J et al. (2004). Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50, 3-32. (Pubitemid 38125696)
29. Rolita L, Holtzer R, Wang C, Lipton RB, Derby CA, Verghese J (2010). Homocysteine and mobility in older adults. J Am Geriatr Soc 58, 545-550.
30. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005). Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293, 1082-1088. (Pubitemid 40300282)
31. Smith AD (2008). The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull 29, S143-S172.
32. Soumare A, Elbaz A, Ducros V, Tavernier B, Alperovitch A, Tzourio C (2006). Cross-sectional association between homocysteine and motor function in the elderly. Neurology 67, 985-990. (Pubitemid 44454589)
33. Speer DC (1992). Clinically significant change: Jacobson and Truax (1991) revisited. J Consult Clin Psychol 60, 402-408.
34. Stel VS, Pluijm SMF, Deeg DJH, Smit JH, Bouter LM, Lips P (2004). Functional limitations and poor physical performance as independent risk factors for self-reported fractures in older persons. Osteoporos Int 15, 742-750. (Pubitemid 39222658)
35. Stel VS, Smit JH, Pluijm SMF, Lips P (2003). Balance and mobility performance as treatable risk factors for recurrent falling in older persons. J Clin Epidemiol 56, 659-668. (Pubitemid 36960183)
36. van Meurs JBJ, Dhonukshe-Rutten RAM, Pluijm SMF, Van Der Klift M, de Jonge R, Lindemans J et al. (2004). Homocysteine levels and the risk of osteoporotic fracture. New Engl J Med 350, 2033-2041.
37. van Schoor NM, Smit JH, Pluijm SM, Jonker C, Lips P (2002). Different cognitive functions in relation to falls among older persons. Immediate memory as an independent risk factor for falls. J Clin Epidemiol 55, 855-862. (Pubitemid 35256085)
38. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J et al. (2007). Vitamin d status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92, 2058-2065. (Pubitemid 46997101)
39. Zhang W, Sun K, Chen J, Liao Y, Qin Q, Ma A et al. (2010). High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci (Lond) 118, 187-194.